GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant. Pennsylvania Governor ...

The upgraded manufacturing campus will be equipped to crank out commercial drugs and vaccines plus house an R&D pilot plant to manufacture medicines for clinical trials. GSK plans to add about 200 ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

The US sets an ambitious target to add 200 GW of new nuclear capacity by 2050, aiming to triple its 2020 levels.

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

This multi-million dollar investment, which is GSK’s largest ever in the United States, will be accompanied ... house a state-of-the-art R&D pilot plant to manufacture medicines for clinical ...

Ascend Advanced Therapies, which has been on an expansion tear since debuting three years ago, inked a deal with EW ...

Deals signed by Google, Amazon, and Microsoft with U.S. nuclear developers will help to deploy a new generation of reactors.

Constellation Energy has applied to reopen a nuclear power plant on Three Mile Island in the Susquehanna — not the one shut after a coolant failure in 1979, but its long-running neighbor, closed by ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

The opaque plumes of noxious smoke billowing out of a Georgia chemical plant are long gone ... which remains under investigation by the US Chemical Safety Board. But the blaze turned into a ...